| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | synapse organization | SDK2 MAP1B PCLO L1CAM ZMYND8 CAST CHAT NECTIN3 PDLIM5 OPRPN SETD5 SLITRK5 BSN CDH1 CDH2 ADGRL3 EPHA4 EPHA5 | 2.34e-06 | 685 | 149 | 18 | GO:0050808 |
| GeneOntologyBiologicalProcess | synapse assembly | SDK2 MAP1B PCLO L1CAM NECTIN3 PDLIM5 SETD5 SLITRK5 BSN CDH1 CDH2 ADGRL3 | 2.54e-06 | 308 | 149 | 12 | GO:0007416 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | SDK2 PCDHGA4 TRO PCDHGA1 L1CAM CDHR5 NECTIN3 WNK1 SLITRK5 CDH1 CDH2 ADGRL3 | 3.00e-06 | 313 | 149 | 12 | GO:0098742 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | DMTF1 NCOA6 HIF1A ZNF143 ZNF148 ARID4B PPRC1 ECD ZMYND8 PRPF6 POGZ RFX7 ATF2 ATF6B BPTF KMT2C PRDM10 NAMPT MRTFB TCERG1 GLI2 ZFP64 CBX7 TAF4B CAMTA1 MGA | 6.84e-06 | 1390 | 149 | 26 | GO:0045944 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 8.95e-06 | 187 | 149 | 9 | GO:0007156 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SELPLG SDK2 HLA-DQA1 PCDHGA4 TRO PCDHGA1 L1CAM CDHR5 NECTIN3 PTAFR RUNX3 WNK1 PDLIM5 BAIAP2L1 EBI3 GLI2 CD34 SLITRK5 CDH1 CDH2 VSIG10L2 ADGRL3 | 9.93e-06 | 1077 | 149 | 22 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell junction organization | SDK2 MAP1B PCLO L1CAM ZMYND8 CAST CHAT NECTIN3 BCR PDLIM5 OPRPN XIRP2 SETD5 SLITRK5 BSN CDH1 CDH2 ADGRL3 EPHA4 EPHA5 | 2.43e-05 | 974 | 149 | 20 | GO:0034330 |
| GeneOntologyBiologicalProcess | presynaptic active zone organization | 4.27e-05 | 10 | 149 | 3 | GO:1990709 | |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 1.55e-04 | 3 | 149 | 2 | GO:0099526 | |
| GeneOntologyBiologicalProcess | brain development | HSPG2 NCOA6 HIF1A ZNF148 MAS1 GIT2 PTCH1 BCR ATF2 OPRPN BPTF MRTFB GLI2 SLITRK5 CDH1 CDH2 EPHA5 | 1.61e-04 | 859 | 149 | 17 | GO:0007420 |
| GeneOntologyBiologicalProcess | columnar/cuboidal epithelial cell differentiation | 1.93e-04 | 164 | 149 | 7 | GO:0002065 | |
| GeneOntologyBiologicalProcess | maintenance of synapse structure | 1.95e-04 | 40 | 149 | 4 | GO:0099558 | |
| GeneOntologyCellularComponent | trans-Golgi network | 9.87e-05 | 306 | 155 | 10 | GO:0005802 | |
| GeneOntologyCellularComponent | asymmetric synapse | MAP1B PCLO CAST ARFGEF2 NECTIN3 BCR PDLIM5 SLITRK5 DMD BSN CDH2 EPHA4 | 2.37e-04 | 477 | 155 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | axon | HIF1A MAP1B PCLO L1CAM LMTK2 CHAT GIT2 NECTIN3 PTCH1 BCR DMD BSN CDH1 USH2A ADGRL3 EPHA4 EPHA5 | 3.40e-04 | 891 | 155 | 17 | GO:0030424 |
| GeneOntologyCellularComponent | neuron projection terminus | 3.57e-04 | 233 | 155 | 8 | GO:0044306 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TPR UIMC1 NCOA6 HIF1A ZNF143 ERCC5 ARID4B PRPF6 RUNX3 ATF2 NXT2 ATF6B BPTF KMT2C PHC3 SETD5 TAF7L NFRKB CBX7 RBM5 TAF4B MGA | 5.35e-04 | 1377 | 155 | 22 | GO:0140513 |
| GeneOntologyCellularComponent | neuron to neuron synapse | MAP1B PCLO CAST ARFGEF2 NECTIN3 BCR PDLIM5 SLITRK5 DMD BSN CDH2 EPHA4 | 5.41e-04 | 523 | 155 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic density | MAP1B PCLO CAST NECTIN3 BCR PDLIM5 SLITRK5 DMD BSN CDH2 EPHA4 | 5.58e-04 | 451 | 155 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | cell surface | HLA-DQA1 MAS1 L1CAM MUC16 OPRPN EBI3 MUC17 CD34 MICB VCAN ROS1 STRC DMD BSN CDH1 CDH2 DCBLD2 EPHA4 EPHA5 | 5.86e-04 | 1111 | 155 | 19 | GO:0009986 |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 8.04e-04 | 6 | 155 | 2 | GO:0098683 | |
| GeneOntologyCellularComponent | adherens junction | 1.05e-03 | 212 | 155 | 7 | GO:0005912 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.32e-03 | 109 | 155 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | postsynaptic specialization | MAP1B PCLO CAST NECTIN3 BCR PDLIM5 SLITRK5 DMD BSN CDH2 EPHA4 | 1.35e-03 | 503 | 155 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.42e-03 | 164 | 155 | 6 | GO:0098982 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 1.49e-03 | 8 | 155 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | ribbon synapse | 1.69e-03 | 32 | 155 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 1.77e-03 | 443 | 155 | 10 | GO:0098791 | |
| GeneOntologyCellularComponent | clathrin-sculpted glutamate transport vesicle membrane | 1.90e-03 | 9 | 155 | 2 | GO:0060203 | |
| GeneOntologyCellularComponent | clathrin-sculpted glutamate transport vesicle | 1.90e-03 | 9 | 155 | 2 | GO:0060199 | |
| HumanPheno | Abnormal stomach morphology | HSPG2 MAP1B HLA-DQA1 VPS13C KIAA0586 ARFGEF2 CHAT POGZ PTCH1 WNK1 BCR KMT2C ALMS1 GLI2 LTBP1 LRBA CAMTA1 CDH1 SON | 8.64e-06 | 742 | 46 | 19 | HP:0002577 |
| HumanPheno | Abnormality of the philtrum | TPR HSPG2 ZNF148 MAP1B TMEM237 PCLO POGZ PTCH1 RFX7 BCR BPTF SETD5 GLI2 CEP295 LTBP1 CAMTA1 CDH2 SON | 2.66e-05 | 726 | 46 | 18 | HP:0000288 |
| HumanPheno | Occipital meningocele | 3.74e-05 | 8 | 46 | 3 | HP:0002436 | |
| Domain | LRRC37AB_C | 1.94e-06 | 4 | 148 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 1.94e-06 | 4 | 148 | 3 | PF14914 | |
| Domain | LRRC37_N | 1.94e-06 | 4 | 148 | 3 | IPR032754 | |
| Domain | LRRC37 | 1.94e-06 | 4 | 148 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 1.94e-06 | 4 | 148 | 3 | IPR015753 | |
| Domain | fn3 | 4.54e-05 | 162 | 148 | 8 | PF00041 | |
| Domain | Znf_piccolo | 6.24e-05 | 2 | 148 | 2 | IPR008899 | |
| Domain | zf-piccolo | 6.24e-05 | 2 | 148 | 2 | PF05715 | |
| Domain | FN3 | 1.15e-04 | 185 | 148 | 8 | SM00060 | |
| Domain | SEA | 1.66e-04 | 14 | 148 | 3 | SM00200 | |
| Domain | ALMS_motif | 1.86e-04 | 3 | 148 | 2 | IPR029299 | |
| Domain | ALMS_motif | 1.86e-04 | 3 | 148 | 2 | PF15309 | |
| Domain | FN3 | 1.90e-04 | 199 | 148 | 8 | PS50853 | |
| Domain | - | HSPG2 SDK2 MXRA5 HLA-DQA1 L1CAM NECTIN3 FNDC7 EBI3 MICB VCAN ROS1 CAMTA1 USH2A EPHA4 EPHA5 | 2.55e-04 | 663 | 148 | 15 | 2.60.40.10 |
| Domain | FN3_dom | 2.66e-04 | 209 | 148 | 8 | IPR003961 | |
| Domain | Ig-like_fold | HSPG2 SDK2 MXRA5 HLA-DQA1 L1CAM NECTIN3 FNDC7 EBI3 MICB VCAN ROS1 CAMTA1 USH2A EPHA4 EPHA5 | 4.95e-04 | 706 | 148 | 15 | IPR013783 |
| Domain | SEA | 6.72e-04 | 22 | 148 | 3 | PF01390 | |
| Domain | G_PATCH | 7.69e-04 | 23 | 148 | 3 | PS50174 | |
| Domain | G_patch | 7.69e-04 | 23 | 148 | 3 | SM00443 | |
| Domain | G_patch_dom | 7.69e-04 | 23 | 148 | 3 | IPR000467 | |
| Domain | SEA | 7.69e-04 | 23 | 148 | 3 | PS50024 | |
| Domain | G-patch | 7.69e-04 | 23 | 148 | 3 | PF01585 | |
| Domain | SEA_dom | 7.69e-04 | 23 | 148 | 3 | IPR000082 | |
| Domain | OSR1_C | 9.16e-04 | 6 | 148 | 2 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 9.16e-04 | 6 | 148 | 2 | IPR024678 | |
| Domain | Znf_FYVE_PHD | 1.13e-03 | 147 | 148 | 6 | IPR011011 | |
| Domain | Cadherin_pro | 1.28e-03 | 7 | 148 | 2 | PF08758 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 6.57e-06 | 133 | 105 | 8 | M16476 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND | 2.28e-05 | 77 | 105 | 6 | M41822 | |
| Pathway | WP_NAD_METABOLISM_SIRTUINS_AND_AGING | 6.34e-05 | 11 | 105 | 3 | M39439 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | UIMC1 NCOA6 CHAF1B HIF1A ATXN7L2 ZNF148 ARID4B TMEM237 ZMYND8 SRSF11 PRPF6 POGZ GPATCH8 RRBP1 RFX7 ATF2 BPTF SCAF1 KMT2C ZBTB44 PHC3 TCERG1 ZFP64 NFRKB RBM5 PHF14 MGA SON | 4.67e-12 | 1294 | 156 | 28 | 30804502 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DMTF1 NCOA6 TRO ZMYND8 PTCH1 WNK1 PHC3 MRTFB BAIAP2L1 XIRP2 GLI2 CAMTA1 BSN MGA ADGRL3 WNK2 SON | 1.22e-11 | 430 | 156 | 17 | 35044719 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR UIMC1 NCOA6 CHAF1B ERCC5 ZNF148 ARID4B ZMYND8 CAST ARFGEF2 POGZ GPATCH8 RRBP1 RFX7 ATF2 BPTF SCAF1 PHC3 NFRKB PHF14 SON | 4.91e-11 | 774 | 156 | 21 | 15302935 |
| Pubmed | ZNF148 HSPBAP1 ZMYND8 ARFGEF2 GPATCH8 RFX7 BIRC6 BPTF KMT2C ZBTB44 GLI2 RBM5 RNF111 EPHA4 | 4.20e-10 | 335 | 156 | 14 | 15741177 | |
| Pubmed | TPR NCOA6 ZNF148 MAP1B CAST POGZ PDLIM5 BPTF KMT2C MRTFB ALMS1 TCERG1 NFRKB LRBA MGA GCN1 | 4.16e-09 | 549 | 156 | 16 | 38280479 | |
| Pubmed | DMTF1 HIF1A ZNF143 ZNF148 HSPBAP1 ZBTB43 ZMYND8 ZNF202 POGZ ZNF236 RUNX3 ATF2 ATF6B PDLIM5 BPTF ZBTB44 ZFP64 PHF14 MGA | 4.57e-09 | 808 | 156 | 19 | 20412781 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR UIMC1 NCOA6 ZNF143 ZNF148 ARID4B MAP1B ZMYND8 CAST SRSF11 PRPF6 POGZ RRBP1 BPTF PHC3 TCERG1 NFRKB PHF14 MGA SON | 1.19e-08 | 954 | 156 | 20 | 36373674 |
| Pubmed | DMTF1 TPR ERCC5 PPRC1 CAST LMTK2 WASHC3 GPATCH8 PTCH1 WNK1 ATF2 KMT2C PHC3 SETD5 VCAN NFRKB CRYBG1 CEP295 CAMTA1 MGA CDH1 | 1.95e-08 | 1084 | 156 | 21 | 11544199 | |
| Pubmed | UIMC1 ERCC5 MAP1B PPRC1 PCDHGA4 TRO PCDHGA1 PCLO ECD SRSF11 PRPF6 RRBP1 BPTF SETD5 RBM5 DNAJC5 PHF14 CEP295 DMD BSN CDH1 CFAP69 DOP1A EPHA4 | 3.11e-08 | 1442 | 156 | 24 | 35575683 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HIF1A MAP1B VPS13C CAST WASHC3 SRSF11 CPD RRBP1 ZNF236 BCR BPTF KMT2C MRTFB SETD5 GLI2 ZFP64 RBM5 PHF14 LRBA CAMTA1 CFAP69 CRAMP1 WNK2 DOP1A | 5.66e-08 | 1489 | 156 | 24 | 28611215 |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA6 ZNF148 ARID4B POGZ RFX7 BPTF KMT2C ALMS1 NFRKB MGA CDH1 CDH2 | 7.09e-08 | 351 | 156 | 12 | 38297188 |
| Pubmed | 8.09e-08 | 225 | 156 | 10 | 12168954 | ||
| Pubmed | ATP7B VPS13C NECTIN3 GPATCH8 RRBP1 WNK1 BCR BIRC6 PDLIM5 ALMS1 NFRKB RBM5 DNAJC5 CEP295 MGA RWDD4 | 2.22e-07 | 733 | 156 | 16 | 34672954 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR UIMC1 ZNF148 MAP1B ECD ZMYND8 CAST RRBP1 WNK1 PDLIM5 PHC3 NAMPT MRTFB ALMS1 TCERG1 LRBA GCN1 SON | 2.35e-07 | 934 | 156 | 18 | 33916271 |
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 22419166 | ||
| Pubmed | 3.53e-07 | 4 | 156 | 3 | 12686612 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | CHAF1B ZNF148 ARID4B ZBTB43 ZMYND8 PRPF6 POGZ RUNX3 PDLIM5 ZBTB44 TCERG1 ZFP64 MGA SON | 4.27e-07 | 583 | 156 | 14 | 29844126 |
| Pubmed | TPR ZNF148 ZMYND8 POGZ BCR BIRC6 PHC3 MRTFB ALMS1 LRBA MGA GCN1 | 4.60e-07 | 418 | 156 | 12 | 34709266 | |
| Pubmed | 4.96e-07 | 35 | 156 | 5 | 18676816 | ||
| Pubmed | 5.03e-07 | 105 | 156 | 7 | 9628581 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 NCOA6 PPRC1 L1CAM ARFGEF2 LMTK2 PTCH1 ZNF236 WNK1 BCR BIRC6 SCAF1 KMT2C SETD5 LRBA SYVN1 GCN1 CRAMP1 WNK2 | 5.98e-07 | 1105 | 156 | 19 | 35748872 |
| Pubmed | CHAF1B ATXN7L2 ZNF148 ATP7B ARID4B RBL1 ZMYND8 POGZ BCR BPTF SCAF1 ALMS1 SETD5 TAF7L NFRKB CEP295 TAF4B MGA SON | 6.93e-07 | 1116 | 156 | 19 | 31753913 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | CHAF1B ZNF148 ZMYND8 POGZ BPTF PHC3 ZNF800 BAIAP2L1 TCERG1 SETD5 NFRKB LTBP1 MGA | 9.44e-07 | 533 | 156 | 13 | 30554943 |
| Pubmed | 1.05e-06 | 117 | 156 | 7 | 17145500 | ||
| Pubmed | 1.18e-06 | 233 | 156 | 9 | 37704626 | ||
| Pubmed | 1.55e-06 | 124 | 156 | 7 | 20850016 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.66e-06 | 313 | 156 | 10 | 38270169 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR CHAF1B ZNF143 ZNF148 ARID4B MAP1B RBL1 TRO ZMYND8 POGZ RRBP1 ATF2 BPTF PRDM10 TCERG1 MGA | 1.72e-06 | 857 | 156 | 16 | 25609649 |
| Pubmed | TPR ARID4B GPATCH8 ZNF236 WNK1 BIRC6 SCAF1 KMT2C PRDM10 NAMPT SERPINB4 NFRKB RBM5 PHF14 LTBP1 SYVN1 MGA GCN1 RWDD4 CRAMP1 | 2.25e-06 | 1327 | 156 | 20 | 32694731 | |
| Pubmed | APPBP2 PPRC1 TRO ZBTB43 POGZ GPATCH8 SETD5 CAMTA1 SYVN1 ADGRL3 SON | 2.52e-06 | 407 | 156 | 11 | 12693553 | |
| Pubmed | DMTF1 UIMC1 HSPG2 NCOA6 ZMYND8 ARFGEF2 RRBP1 ZBTB44 MRTFB EBI3 MGA RNF111 SON | 2.94e-06 | 591 | 156 | 13 | 15231748 | |
| Pubmed | 3.23e-06 | 23 | 156 | 4 | 30814516 | ||
| Pubmed | HSPG2 ERCC5 ATXN7L2 TRO ZMYND8 GPATCH8 WNK1 PDLIM5 HSPA13 SCAF1 LTBP1 SYVN1 WNK2 | 3.99e-06 | 608 | 156 | 13 | 16713569 | |
| Pubmed | 4.88e-06 | 8 | 156 | 3 | 7750641 | ||
| Pubmed | NCOA6 SDK2 VPS13C LMTK2 POGZ RRBP1 BCR KMT2C BSN CRAMP1 CFAP97 WNK2 | 5.25e-06 | 529 | 156 | 12 | 14621295 | |
| Pubmed | UIMC1 HSPG2 NCOA6 ZNF143 ATXN7L2 ZNF148 ARID4B ZMYND8 POGZ GPATCH8 RFX7 BPTF KMT2C PHC3 ALMS1 TCERG1 GLI2 NFRKB MGA FILIP1L | 6.76e-06 | 1429 | 156 | 20 | 35140242 | |
| Pubmed | 7.29e-06 | 9 | 156 | 3 | 20386748 | ||
| Pubmed | 7.29e-06 | 9 | 156 | 3 | 18816447 | ||
| Pubmed | 7.29e-06 | 9 | 156 | 3 | 33530552 | ||
| Pubmed | 7.29e-06 | 9 | 156 | 3 | 23916850 | ||
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 9.75e-06 | 30 | 156 | 4 | 32882513 | |
| Pubmed | 1.04e-05 | 10 | 156 | 3 | 23064749 | ||
| Pubmed | 1.04e-05 | 10 | 156 | 3 | 28882402 | ||
| Pubmed | Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131. | 1.08e-05 | 110 | 156 | 6 | 26841866 | |
| Pubmed | 1.34e-05 | 486 | 156 | 11 | 20936779 | ||
| Pubmed | 1.42e-05 | 11 | 156 | 3 | 21038445 | ||
| Pubmed | Role of cell and matrix-bound VEGF isoforms in lens development. | 1.42e-05 | 11 | 156 | 3 | 18757513 | |
| Pubmed | 1.42e-05 | 11 | 156 | 3 | 28673820 | ||
| Pubmed | 1.42e-05 | 11 | 156 | 3 | 38750698 | ||
| Pubmed | 1.42e-05 | 11 | 156 | 3 | 15668330 | ||
| Pubmed | 1.42e-05 | 11 | 156 | 3 | 39029571 | ||
| Pubmed | 1.69e-05 | 119 | 156 | 6 | 23508102 | ||
| Pubmed | Transcriptional analysis of cleft palate in TGFβ3 mutant mice. | 1.83e-05 | 35 | 156 | 4 | 32913205 | |
| Pubmed | 1.89e-05 | 12 | 156 | 3 | 26929452 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 22970168 | ||
| Pubmed | Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1. | 2.00e-05 | 2 | 156 | 2 | 16828081 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 24486622 | ||
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 2.00e-05 | 2 | 156 | 2 | 23403927 | |
| Pubmed | Rescuing the N-cadherin knockout by cardiac-specific expression of N- or E-cadherin. | 2.00e-05 | 2 | 156 | 2 | 11171330 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 20032301 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 23653235 | ||
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 2.00e-05 | 2 | 156 | 2 | 26793095 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 30829665 | ||
| Pubmed | Cadherin-mediated cell sorting not determined by binding or adhesion specificity. | 2.00e-05 | 2 | 156 | 2 | 11790800 | |
| Pubmed | Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. | 2.00e-05 | 2 | 156 | 2 | 23002209 | |
| Pubmed | Prognostic significance of E-cadherin and N-cadherin expression in Gliomas. | 2.00e-05 | 2 | 156 | 2 | 28851312 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 14675278 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 32632164 | ||
| Pubmed | Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology. | 2.00e-05 | 2 | 156 | 2 | 12354790 | |
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 2.00e-05 | 2 | 156 | 2 | 21935939 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 28628116 | ||
| Pubmed | Regulation of Nampt expression by transcriptional coactivator NCOA6 in pancreatic β-cells. | 2.00e-05 | 2 | 156 | 2 | 28435063 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 33979097 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 12057916 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 15153430 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 36010583 | ||
| Pubmed | E-cadherin can replace N-cadherin during secretory-stage enamel development. | 2.00e-05 | 2 | 156 | 2 | 25014356 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 35500674 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 24891510 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 20156840 | ||
| Pubmed | WNK Inhibition Increases Surface Liquid pH and Host Defense in Cystic Fibrosis Airway Epithelia. | 2.00e-05 | 2 | 156 | 2 | 35849656 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 24914828 | ||
| Pubmed | Visfatin in adipocytes is upregulated by hypoxia through HIF1alpha-dependent mechanism. | 2.00e-05 | 2 | 156 | 2 | 16970912 | |
| Pubmed | Modulation of E-Cadherin and N-Cadherin by ovarian steroids and embryonic stimuli. | 2.00e-05 | 2 | 156 | 2 | 34710830 | |
| Pubmed | The role of E and N-cadherin in the postoperative course of gonadotroph pituitary tumours. | 2.00e-05 | 2 | 156 | 2 | 30051197 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 28278175 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 24163134 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 18025805 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 22072429 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 23771665 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 25607384 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 30968151 | ||
| Pubmed | HIF-1α Activates Hypoxia-Induced MXRA5 Expression in the Progression of Ovarian Cancer. | 2.00e-05 | 2 | 156 | 2 | 39462449 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 19712049 | ||
| Pubmed | Epigenetic silencing of E- and N-cadherins in the stroma of mouse thymic lymphomas. | 2.00e-05 | 2 | 156 | 2 | 16377805 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 19919954 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 18688029 | ||
| Pubmed | Molecular design principles underlying β-strand swapping in the adhesive dimerization of cadherins. | 2.00e-05 | 2 | 156 | 2 | 21572446 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 27321892 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 20451421 | ||
| Interaction | H2BC9 interactions | HIF1A MAP1B TRO PCLO SRSF11 TEX15 GPATCH8 RRBP1 ADGRG4 BPTF SCAF1 OTOF XIRP2 SPON2 RBM5 | 1.62e-06 | 446 | 153 | 15 | int:H2BC9 |
| Interaction | FEV interactions | NCOA6 ZNF143 ZNF148 ARID4B POGZ GPATCH8 KMT2C PHC3 NFRKB MGA | 3.54e-06 | 203 | 153 | 10 | int:FEV |
| Interaction | RAB11A interactions | TPR SDK2 VPS13C MUC19 ARFGEF2 LMTK2 CPD NECTIN3 RRBP1 PTCH1 BIRC6 ATF2 PDLIM5 BAIAP2L1 SERPINB4 SLITRK5 DNAJC5 LRBA DCBLD2 DOP1A | 4.95e-06 | 830 | 153 | 20 | int:RAB11A |
| Interaction | EGR2 interactions | 6.47e-06 | 171 | 153 | 9 | int:EGR2 | |
| Interaction | HNF4A interactions | NCOA6 HIF1A ZNF148 ARID4B MUC19 POGZ BPTF KMT2C NFRKB DMD MGA | 8.43e-06 | 275 | 153 | 11 | int:HNF4A |
| Interaction | FHL2 interactions | HIF1A ZNF143 ARID4B POGZ PTCH1 WNK1 PHC3 MRTFB ALMS1 ODAM ZFP64 RBM5 RNF111 | 1.07e-05 | 396 | 153 | 13 | int:FHL2 |
| Interaction | HDAC1 interactions | TPR HIF1A ZNF148 ARID4B RBL1 ZBTB43 ZMYND8 RUNX3 BCR BIRC6 PDLIM5 BPTF ZNF800 MRTFB ALMS1 GLI2 ZFP64 PHF14 LRBA MGA CDH1 GCN1 | 3.34e-05 | 1108 | 153 | 22 | int:HDAC1 |
| Interaction | ELF1 interactions | 5.03e-05 | 126 | 153 | 7 | int:ELF1 | |
| Interaction | NFYC interactions | 6.33e-05 | 177 | 153 | 8 | int:NFYC | |
| Interaction | ITGB2 interactions | 6.76e-05 | 132 | 153 | 7 | int:ITGB2 | |
| Interaction | SMC5 interactions | TPR UIMC1 NCOA6 ZNF143 ZNF148 ARID4B MAP1B ZMYND8 CAST SRSF11 PRPF6 POGZ RRBP1 BPTF PHC3 TCERG1 NFRKB PHF14 MGA SON | 7.12e-05 | 1000 | 153 | 20 | int:SMC5 |
| Interaction | TERF2IP interactions | UIMC1 NCOA6 CHAF1B ERCC5 ZNF148 ZMYND8 SRSF11 POGZ BPTF PHC3 TCERG1 NFRKB RBM5 MGA | 8.32e-05 | 552 | 153 | 14 | int:TERF2IP |
| Interaction | NUP43 interactions | NCOA6 ERCC5 ARID4B ZMYND8 MUC19 PRPF6 POGZ GPATCH8 BPTF SCAF1 PHC3 MRTFB NFRKB MGA SON | 8.54e-05 | 625 | 153 | 15 | int:NUP43 |
| Interaction | BRD3 interactions | CHAF1B ZNF148 ZMYND8 POGZ BPTF SCAF1 TCERG1 SETD5 NFRKB LTBP1 TAF4B MGA SON | 1.04e-04 | 494 | 153 | 13 | int:BRD3 |
| Interaction | PAX6 interactions | NCOA6 ZNF148 ARID4B WASHC3 SRSF11 POGZ BPTF KMT2C NFRKB MGA RNF111 | 1.14e-04 | 366 | 153 | 11 | int:PAX6 |
| Interaction | CSNK2A2 interactions | ERCC5 ARID4B RBL1 ZMYND8 GIT2 PTCH1 BCR ATF2 DNAAF2 PHC3 RBM5 PHF14 MGA GCN1 CFAP97 RNF111 | 1.17e-04 | 718 | 153 | 16 | int:CSNK2A2 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 2.09e-04 | 157 | 156 | 5 | chr4q13 | |
| Cytoband | 4q13.3 | 4.01e-04 | 42 | 156 | 3 | 4q13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q24 | 5.14e-04 | 191 | 156 | 5 | chr11q24 | |
| Cytoband | 9q22.3 | 7.40e-04 | 12 | 156 | 2 | 9q22.3 | |
| GeneFamily | Fibronectin type III domain containing | 2.95e-06 | 160 | 100 | 8 | 555 | |
| GeneFamily | CD molecules|Mucins | 4.91e-06 | 21 | 100 | 4 | 648 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 2.34e-04 | 22 | 100 | 3 | 579 | |
| GeneFamily | CD molecules|Type I classical cadherins | 3.00e-04 | 5 | 100 | 2 | 1185 | |
| GeneFamily | PHD finger proteins | 1.56e-03 | 90 | 100 | 4 | 88 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.01e-03 | 161 | 100 | 5 | 593 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.64e-03 | 14 | 100 | 2 | 1095 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 2.82e-03 | 51 | 100 | 3 | 870 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.03e-03 | 15 | 100 | 2 | 26 | |
| Coexpression | GABRIELY_MIR21_TARGETS | SRSF11 RFX7 WNK1 ATF2 GLCCI1 ZBTB44 CRYBG1 DMD MGA EPHA4 FILIP1L | 1.29e-06 | 289 | 155 | 11 | M2196 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | MXRA5 VPS13C LRRC37A2 SRSF11 POGZ RRBP1 BCR GLCCI1 PDLIM5 PHC3 NAMPT MRTFB ALMS1 CBX7 RBM5 DNAJC5 DMD EPHA4 | 1.47e-06 | 807 | 155 | 18 | M16651 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DMTF1 SELPLG TPR ZNF148 ARID4B VPS13C GIT2 GPATCH8 RFX7 RUNX3 WNK1 BIRC6 ATF2 GLCCI1 BPTF KMT2C ZBTB44 PHC3 ZNF800 SETD5 MICB CBX7 CRYBG1 LRBA SON | 2.32e-06 | 1492 | 155 | 25 | M40023 |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 4.87e-06 | 211 | 155 | 9 | MM17081 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | DMTF1 NCOA6 APPBP2 ZNF143 ARID4B HSPBAP1 ZBTB43 ARFGEF2 ZNF202 SRSF11 GPATCH8 CCNJ ATF2 HSPA13 PRDM10 NAMPT SETD5 | 7.96e-06 | 822 | 155 | 17 | M6782 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 1.15e-05 | 85 | 155 | 6 | M10575 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.23e-05 | 180 | 155 | 8 | M8239 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.26e-05 | 300 | 155 | 10 | M8702 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | APPBP2 HIF1A ZNF148 MAP1B ZMYND8 NECTIN3 GPATCH8 ATF2 PDLIM5 BPTF NAMPT PHF14 DMD CDH2 EPHA4 SON FILIP1L | 1.34e-05 | 856 | 155 | 17 | M4500 |
| Coexpression | GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP | 2.64e-05 | 200 | 155 | 8 | M6535 | |
| Coexpression | EIF4E_DN | 2.93e-05 | 100 | 155 | 6 | M2790 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 6.10e-05 | 166 | 155 | 7 | M6826 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NCOA6 ARID4B MAP1B PCLO KIAA0586 ARFGEF2 SRSF11 PRPF6 NECTIN3 ZNF800 NAMPT ALMS1 TCERG1 SLITRK5 PHF14 CEP295 STRC LRBA DMD CDH1 CFAP69 CDH2 WNK2 EPHA5 | 9.07e-08 | 989 | 148 | 24 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | NCOA6 MAP1B PCLO KIAA0586 CPD PRPF6 GIT2 NECTIN3 ATF2 ZNF800 MRTFB ALMS1 TCERG1 GLI2 RBM5 PHF14 CEP295 DMD CFAP69 CDH2 EPHA5 | 3.28e-07 | 831 | 148 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | ZNF148 SRSF11 CPD TEX15 BIRC6 KMT2C ZBTB44 ZNF800 TAF7L RBM5 CEP295 TAF4B MGA CFAP97 | 5.70e-07 | 387 | 148 | 14 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | HIF1A MAP1B SRSF11 CPD BIRC6 PDLIM5 HSPA13 ZBTB44 SETD5 VCAN CDH2 GCN1 DCBLD2 EPHA4 | 7.72e-07 | 397 | 148 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | APPBP2 ZNF148 ARID4B CPD RFX7 HSPA13 ZBTB44 NAMPT VCAN LTBP1 RWDD4 ADGRL3 EPHA4 SON EPHA5 | 1.88e-06 | 492 | 148 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | HIF1A MAP1B SRSF11 CPD BIRC6 PDLIM5 HSPA13 ZBTB44 SETD5 VCAN ADGRL3 EPHA4 | 3.59e-06 | 330 | 148 | 12 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | APPBP2 HIF1A ZNF148 MAP1B SRSF11 CPD BIRC6 PDLIM5 HSPA13 ZBTB44 SETD5 VCAN CDH2 GCN1 DCBLD2 CFAP97 EPHA4 SON ARMH4 | 3.80e-06 | 811 | 148 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | DMTF1 ARID4B MAP1B RBL1 TRO PCLO KIAA0586 PRPF6 GPATCH8 WNK1 BPTF SETD5 CEP295 CDH2 CRAMP1 SON | 4.23e-06 | 595 | 148 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | TPR SDK2 MAP1B HLA-DQA1 PCLO L1CAM KIAA0586 SRSF11 NECTIN3 CCNJ RUNX3 ZNF800 ALMS1 SLITRK5 LTBP1 LRBA DMD CDH1 CDH2 WNK2 EPHA4 | 4.98e-06 | 986 | 148 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | HIF1A ZNF148 ERN1 KIAA0586 SRSF11 CPD TEX15 BIRC6 KMT2C ZBTB44 ZNF800 TAF7L RBM5 CEP295 TAF4B CAMTA1 MGA CFAP97 | 1.11e-05 | 795 | 148 | 18 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | NCOA6 ARID4B KIAA0586 ARFGEF2 PRPF6 ALMS1 TCERG1 PHF14 CEP295 STRC LRBA | 1.20e-05 | 311 | 148 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | HIF1A MAP1B ARFGEF2 CHAT SRSF11 CPD BIRC6 ATF2 PDLIM5 HSPA13 ZBTB44 SETD5 VCAN CDH2 RWDD4 ADGRL3 EPHA4 EPHA5 | 1.63e-05 | 818 | 148 | 18 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | TPR MAP1B CPD WNK1 BIRC6 HSPA13 SETD5 VCAN GCN1 ADGRL3 EPHA4 SON | 1.70e-05 | 385 | 148 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | ZNF148 ERN1 HLA-DQA1 SRSF11 CPD TEX15 WNK1 BIRC6 KMT2C ZBTB44 ZNF800 RBM5 CEP295 TAF4B CAMTA1 MGA CFAP97 | 2.73e-05 | 770 | 148 | 17 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | HIF1A ZNF148 SRSF11 CPD TEX15 BIRC6 PDLIM5 KMT2C ZBTB44 ZNF800 ALMS1 TAF7L RBM5 CEP295 TAF4B MGA CFAP97 | 3.01e-05 | 776 | 148 | 17 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | ZNF148 ERN1 SRSF11 CPD TEX15 WNK1 BIRC6 KMT2C ZBTB44 ZNF800 TAF7L RBM5 CEP295 TAF4B CAMTA1 MGA CFAP97 | 3.11e-05 | 778 | 148 | 17 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 5.49e-05 | 139 | 148 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | TPR MAP1B ARFGEF2 CPD HSPA13 ZBTB44 SETD5 VCAN GCN1 DCBLD2 EPHA4 | 5.75e-05 | 369 | 148 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TPR MAP1B CPD WNK1 BIRC6 HSPA13 SETD5 VCAN LTBP1 CDH1 CDH2 GCN1 ADGRL3 EPHA4 SON EPHA5 ARMH4 | 5.79e-05 | 818 | 148 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPR NCOA6 ERCC5 ARID4B RBL1 KIAA0586 ARFGEF2 SRSF11 PRPF6 POGZ CCNJ BPTF ZNF800 ALMS1 TCERG1 SETD5 GLI2 PHF14 CEP295 DMD CDH2 CFAP97 | 6.03e-05 | 1257 | 148 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 6.07e-05 | 247 | 148 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 6.65e-05 | 194 | 148 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.93e-05 | 312 | 148 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | APPBP2 ZNF148 ARID4B CPD RFX7 RUNX3 HSPA13 ZBTB44 NAMPT VCAN LTBP1 CDH2 RWDD4 ADGRL3 EPHA4 SON EPHA5 | 7.56e-05 | 836 | 148 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | CPD TEX15 BIRC6 ZBTB44 ZNF800 TAF7L RBM5 CEP295 TAF4B MGA CFAP97 | 7.84e-05 | 382 | 148 | 11 | gudmap_developingGonad_e14.5_ ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | ZNF148 ERN1 SRSF11 CPD TEX15 ZBTB44 ZNF800 TAF7L RBM5 CEP295 TAF4B | 8.79e-05 | 387 | 148 | 11 | gudmap_developingGonad_e16.5_ovary_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ARID4B TRO KIAA0586 ARFGEF2 SRSF11 PRPF6 WNK1 BPTF SETD5 CEP295 DMD MGA SON EPHA5 | 1.33e-04 | 629 | 148 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 1.61e-04 | 165 | 148 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | TPR MAP1B ARFGEF2 CPD GPATCH8 PTCH1 BIRC6 GLI2 VCAN CAMTA1 CFAP69 GCN1 ADGRL3 EPHA4 EPHA5 ARMH4 | 1.64e-04 | 806 | 148 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | MAP1B PCLO L1CAM KIAA0586 SRSF11 NECTIN3 CCNJ RUNX3 GLCCI1 ZNF800 ALMS1 SLITRK5 DMD CFAP69 CDH2 WNK2 EPHA5 | 1.67e-04 | 893 | 148 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPR NCOA6 ERCC5 ARID4B MAP1B RBL1 KIAA0586 ARFGEF2 SRSF11 PRPF6 POGZ CCNJ BPTF ZNF800 ALMS1 TCERG1 SETD5 GLI2 PHF14 CEP295 DMD CDH2 CFAP97 | 1.93e-04 | 1459 | 148 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | MAP1B PCLO ARFGEF2 SRSF11 PRPF6 NECTIN3 ZNF800 ALMS1 TCERG1 CEP295 CDH1 CDH2 | 1.98e-04 | 498 | 148 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | APPBP2 MAP1B SRSF11 CPD PTCH1 ATF2 PDLIM5 ZBTB44 SETD5 VCAN CDH2 RWDD4 ADGRL3 EPHA4 SON ARMH4 | 2.16e-04 | 826 | 148 | 16 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | TPR ARID4B TRO ARFGEF2 SRSF11 PRPF6 WNK1 CEP295 LRBA MGA FILIP1L | 2.29e-04 | 432 | 148 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.50e-04 | 298 | 148 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | ZNF143 ZNF148 HLA-DQA1 RBL1 ARFGEF2 CPD CCNJ RFX7 BAIAP2L1 VCAN CEP295 LTBP1 CAMTA1 CFAP69 CDH2 | 3.65e-04 | 779 | 148 | 15 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 3.67e-04 | 249 | 148 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#4 | 4.64e-04 | 92 | 148 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | TPR UIMC1 ARID4B HLA-DQA1 MAS1 PCLO ARFGEF2 SRSF11 PPP1R11 NECTIN3 ZNF800 PHF14 LTBP1 STRC CFAP69 EPHA4 FILIP1L | 4.85e-04 | 979 | 148 | 17 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | MAP1B VPS13C PCLO SRSF11 DNAAF2 ZNF800 ALMS1 SLITRK5 PHF14 STRC LRBA DMD CDH2 WNK2 DOP1A FILIP1L EPHA5 | 5.07e-04 | 983 | 148 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 5.41e-04 | 403 | 148 | 10 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | APPBP2 ZNF148 MAP1B KIAA0586 SRSF11 CPD BIRC6 HSPA13 ZBTB44 ZNF800 RBM5 CEP295 MGA CDH2 CFAP97 | 5.83e-04 | 815 | 148 | 15 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | TPR HIF1A ZNF143 ARID4B TRO KIAA0586 ARFGEF2 SRSF11 PRPF6 WNK1 BPTF SETD5 | 6.05e-04 | 564 | 148 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 6.54e-04 | 413 | 148 | 10 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 6.71e-04 | 209 | 148 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.71e-04 | 209 | 148 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.90e-04 | 210 | 148 | 7 | gudmap_developingGonad_e14.5_ ovary_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 7.04e-04 | 417 | 148 | 10 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.06e-04 | 275 | 148 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.12e-04 | 101 | 148 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | MAP1B PCLO SRSF11 NECTIN3 CCNJ RUNX3 ZNF800 SLITRK5 DMD CDH2 WNK2 | 7.30e-04 | 496 | 148 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.82e-04 | 349 | 148 | 9 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | MAP1B ARFGEF2 SRSF11 CPD PDLIM5 SETD5 VCAN ADGRL3 EPHA4 EPHA5 | 8.44e-04 | 427 | 148 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_500 | 8.58e-04 | 27 | 148 | 3 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 8.74e-04 | 429 | 148 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | ZNF143 ZNF148 ARID4B RFX7 RUNX3 HSPA13 GLI2 VCAN LTBP1 CAMTA1 CDH2 ADGRL3 EPHA4 SON EPHA5 | 8.95e-04 | 850 | 148 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 9.24e-04 | 107 | 148 | 5 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.24e-04 | 107 | 148 | 5 | gudmap_developingGonad_e16.5_ovary_1000_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.05e-03 | 110 | 148 | 5 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | NCOA6 RBL1 KIAA0586 ARFGEF2 CPD PRPF6 POGZ GIT2 ATF2 MRTFB GLI2 RBM5 PHF14 CFAP97 | 1.13e-03 | 780 | 148 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TPR ARID4B MAP1B RBL1 KIAA0586 NECTIN3 CCNJ PTCH1 ZNF800 ALMS1 SETD5 PHF14 CEP295 DMD CAMTA1 CDH2 WNK2 | 1.17e-03 | 1060 | 148 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.17e-03 | 168 | 148 | 6 | gudmap_developingGonad_P2_ovary_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.17e-03 | 230 | 148 | 7 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | TPR SDK2 HLA-DQA1 MAS1 SRSF11 GPATCH8 RUNX3 MRTFB LTBP1 DMD CDH1 ADGRL3 WNK2 EPHA4 FILIP1L EPHA5 | 1.19e-03 | 967 | 148 | 16 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | NCOA6 LRRC37A3 ZMYND8 ARFGEF2 PRPF6 PTCH1 VCAN LTBP1 FILIP1L | 1.40e-08 | 178 | 156 | 9 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.68e-08 | 199 | 156 | 9 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.84e-08 | 200 | 156 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-07 | 174 | 156 | 8 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.42e-07 | 188 | 156 | 8 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.71e-07 | 190 | 156 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.18e-07 | 193 | 156 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-07 | 194 | 156 | 8 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-07 | 195 | 156 | 8 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.52e-07 | 195 | 156 | 8 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.70e-07 | 196 | 156 | 8 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.70e-07 | 196 | 156 | 8 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.47e-07 | 200 | 156 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.47e-07 | 200 | 156 | 8 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.84e-06 | 183 | 156 | 7 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-06 | 184 | 156 | 7 | 857ca1fc4de07b300839b22924211dc624453841 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 184 | 156 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 184 | 156 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 184 | 156 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 4.12e-06 | 185 | 156 | 7 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 4.27e-06 | 186 | 156 | 7 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.27e-06 | 186 | 156 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.27e-06 | 186 | 156 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-06 | 187 | 156 | 7 | b7689e7f6511920cd2beff27389555fddf685f61 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.58e-06 | 188 | 156 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-06 | 190 | 156 | 7 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-06 | 191 | 156 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-06 | 191 | 156 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-06 | 191 | 156 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.63e-06 | 194 | 156 | 7 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-06 | 195 | 156 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-06 | 195 | 156 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 196 | 156 | 7 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 196 | 156 | 7 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 196 | 156 | 7 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 196 | 156 | 7 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | proximal-mesenchymal-Myofibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.22e-06 | 197 | 156 | 7 | ab21baea931ff134cf5a7ee369c091230988108b | |
| ToppCell | proximal-mesenchymal-Myofibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.22e-06 | 197 | 156 | 7 | 15f2f169758a07143fc7d1bdb58d0b4d750a0be4 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.22e-06 | 197 | 156 | 7 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | proximal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.22e-06 | 197 | 156 | 7 | c59b64674fb4aaa945c1df7e4a9a3605c7cd2b75 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 6.43e-06 | 198 | 156 | 7 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.65e-06 | 199 | 156 | 7 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 6.65e-06 | 199 | 156 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 9.69e-06 | 139 | 156 | 6 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | Severe-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.67e-05 | 153 | 156 | 6 | 44572f87d403e314050ab935d2cd676c33d9c287 | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.94e-05 | 157 | 156 | 6 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.56e-05 | 165 | 156 | 6 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-05 | 174 | 156 | 6 | c9d4e375dedd2b099a9ed70ec38ff35bbb0ce48a | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-05 | 174 | 156 | 6 | 1463c98f8f519dd030587abbdbeb1b4e1bca5dd1 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-05 | 174 | 156 | 6 | d421c0069d24cb560a3a429929e3cd1eceaeabcf | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.68e-05 | 176 | 156 | 6 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 176 | 156 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Control-Lymphoid-pDC|Control / Condition, Lineage and Cell class | 3.68e-05 | 176 | 156 | 6 | 5de16ff65476bde8b23322a44e11412e14f1bafe | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-05 | 178 | 156 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-05 | 178 | 156 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.04e-05 | 179 | 156 | 6 | bf012825e88626e59cd1deebf67c2cd269ce4829 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.04e-05 | 179 | 156 | 6 | 55fde77dae7f9e7f3431c3185d14212a25af83df | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 180 | 156 | 6 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.30e-05 | 181 | 156 | 6 | fc51468c74534b60b4e786bd512d0f1c5dc05de7 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 182 | 156 | 6 | 9465238ac806fce46dfe1a141e83893f23eb4afb | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.43e-05 | 182 | 156 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.71e-05 | 184 | 156 | 6 | 9690d4290e70f9bda889754ffb30b0af1f7cb94b | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 4.71e-05 | 184 | 156 | 6 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.86e-05 | 185 | 156 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.86e-05 | 185 | 156 | 6 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 185 | 156 | 6 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-05 | 186 | 156 | 6 | b3358e0fa6d845c81e94d56c8575f016621d28ff | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.00e-05 | 186 | 156 | 6 | 8ea708070166c858cd9bd871670655b0114c32a5 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 5.16e-05 | 187 | 156 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.16e-05 | 187 | 156 | 6 | 0dee138738b65531ff134a125b92234b5d0a653c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.31e-05 | 188 | 156 | 6 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-05 | 188 | 156 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.31e-05 | 188 | 156 | 6 | 502045a39ffb1e92bd9499848368e8fa971edb88 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-05 | 189 | 156 | 6 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-05 | 189 | 156 | 6 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.63e-05 | 190 | 156 | 6 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.63e-05 | 190 | 156 | 6 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.80e-05 | 191 | 156 | 6 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 5.80e-05 | 191 | 156 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-05 | 191 | 156 | 6 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | COVID-19_Moderate-Plasmablast|World / disease group, cell group and cell class | 5.80e-05 | 191 | 156 | 6 | bb28703020c5296b65527094d2e5924348275e58 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.80e-05 | 191 | 156 | 6 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.80e-05 | 191 | 156 | 6 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 5.80e-05 | 191 | 156 | 6 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.80e-05 | 191 | 156 | 6 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.80e-05 | 191 | 156 | 6 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.80e-05 | 191 | 156 | 6 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.80e-05 | 191 | 156 | 6 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 5.97e-05 | 192 | 156 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.97e-05 | 192 | 156 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-05 | 192 | 156 | 6 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.97e-05 | 192 | 156 | 6 | ce867b6e78c1d8f30dff81bf572a78a897bc7625 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.97e-05 | 192 | 156 | 6 | 58a7829b411b02b422ef75e2277a868969cc23e8 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.97e-05 | 192 | 156 | 6 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.97e-05 | 192 | 156 | 6 | 1d0d6fb89a2b941b7caab2f1f07d6bd5433a11e7 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-05 | 193 | 156 | 6 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.14e-05 | 193 | 156 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.14e-05 | 193 | 156 | 6 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.32e-05 | 194 | 156 | 6 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | CF-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 6.32e-05 | 194 | 156 | 6 | 3feb8a0ba3368673c53e9cbd4980e73d18697718 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.10e-04 | 49 | 105 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | ZNF143 ARID4B ZMYND8 MRTFB SETD5 ZFP64 RBM5 MGA RNF111 EPHA4 SON | 4.10e-08 | 182 | 152 | 11 | 3887_DN |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | ZNF143 ARID4B PPRC1 ZMYND8 DNAAF2 BPTF MRTFB SETD5 RBM5 MGA RNF111 | 4.59e-08 | 184 | 152 | 11 | 2321_DN |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; ssMCF7; HG-U133A | 8.65e-07 | 197 | 152 | 10 | 415_UP | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | APPBP2 ARID4B HSPBAP1 ZMYND8 NECTIN3 MRTFB SETD5 ZFP64 RNF111 | 3.51e-06 | 180 | 152 | 9 | 4541_DN |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 4.39e-06 | 185 | 152 | 9 | 1114_DN | |
| Drug | AG-012559 [369370-06-9]; Up 200; 10uM; PC3; HT_HG-U133A | 6.20e-06 | 193 | 152 | 9 | 6920_UP | |
| Drug | Napelline [5008-52-6]; Down 200; 11.2uM; HL60; HT_HG-U133A | 7.32e-06 | 197 | 152 | 9 | 2522_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.79e-05 | 179 | 152 | 8 | 5822_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 2.79e-05 | 179 | 152 | 8 | 4585_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 3.15e-05 | 182 | 152 | 8 | 1951_DN | |
| Drug | X-gal | 3.17e-05 | 133 | 152 | 7 | CID000065181 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 3.27e-05 | 183 | 152 | 8 | 7498_DN | |
| Drug | Alsterpaullone; Down 200; 10uM; PC3; HT_HG-U133A | 3.96e-05 | 188 | 152 | 8 | 7078_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HT_HG-U133A | 4.12e-05 | 189 | 152 | 8 | 6750_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 4.27e-05 | 190 | 152 | 8 | 4306_DN | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A | 4.43e-05 | 191 | 152 | 8 | 6644_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 4.43e-05 | 191 | 152 | 8 | 3926_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 4.95e-05 | 194 | 152 | 8 | 4281_DN | |
| Drug | Dichlorphenamide [120-97-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 4.95e-05 | 194 | 152 | 8 | 3366_DN | |
| Drug | Amoxicillin [26787-78-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 5.13e-05 | 195 | 152 | 8 | 5385_UP | |
| Drug | Iodixanol [92339-11-2]; Up 200; 2.6uM; MCF7; HT_HG-U133A | 5.13e-05 | 195 | 152 | 8 | 4848_UP | |
| Drug | AG-028671 [847803-03-6]; Down 200; 10uM; PC3; HT_HG-U133A | 5.32e-05 | 196 | 152 | 8 | 6582_DN | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 5.32e-05 | 196 | 152 | 8 | 5919_UP | |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 5.32e-05 | 196 | 152 | 8 | 4390_UP | |
| Drug | Ifenprodil tartrate [23210-58-4]; Up 200; 8.4uM; HL60; HT_HG-U133A | 5.72e-05 | 198 | 152 | 8 | 2372_UP | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 5.72e-05 | 198 | 152 | 8 | 4701_UP | |
| Drug | genistein; Up 200; 10uM; MCF7; HG-U133A | 5.92e-05 | 199 | 152 | 8 | 638_UP | |
| Drug | PTFE | 7.58e-05 | 34 | 152 | 4 | CID000008301 | |
| Disease | Adenoid Cystic Carcinoma | 1.30e-05 | 100 | 151 | 6 | C0010606 | |
| Disease | thyroid gland papillary carcinoma (is_marker_for) | 4.59e-05 | 14 | 151 | 3 | DOID:3969 (is_marker_for) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.63e-04 | 157 | 151 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | Disease Exacerbation | 2.13e-04 | 165 | 151 | 6 | C0235874 | |
| Disease | 2-hydroxyoctanoate measurement | 2.58e-04 | 5 | 151 | 2 | EFO_0800192 | |
| Disease | Basal Cell Nevus Syndrome | 2.58e-04 | 5 | 151 | 2 | C0004779 | |
| Disease | mental development measurement | 2.78e-04 | 25 | 151 | 3 | EFO_0008230 | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 3.85e-04 | 6 | 151 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 3.85e-04 | 6 | 151 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | NCOA6 HIF1A ATP7B LRRC37A2 ARFGEF2 WNK1 ATF2 LRRC37A OTOF ZFP64 LRBA DMD CDH1 CDH2 DOP1A | 4.24e-04 | 1074 | 151 | 15 | C0006142 |
| Disease | pulmonary tuberculosis | 4.35e-04 | 29 | 151 | 3 | EFO_1000049 | |
| Disease | cognitive function measurement, self reported educational attainment | 5.07e-04 | 355 | 151 | 8 | EFO_0004784, EFO_0008354 | |
| Disease | stomach cancer (is_implicated_in) | 5.17e-04 | 72 | 151 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | pemphigus (is_implicated_in) | 5.37e-04 | 7 | 151 | 2 | DOID:9182 (is_implicated_in) | |
| Disease | Periventricular Nodular Heterotopia | 5.37e-04 | 7 | 151 | 2 | C1868720 | |
| Disease | Large cell carcinoma of lung | 5.84e-04 | 32 | 151 | 3 | C0345958 | |
| Disease | 2-aminooctanoate measurement | 7.14e-04 | 8 | 151 | 2 | EFO_0800349 | |
| Disease | rosacea severity measurement | 9.79e-04 | 147 | 151 | 5 | EFO_0009180 | |
| Disease | myositis | 1.05e-03 | 39 | 151 | 3 | EFO_0000783 | |
| Disease | feeling nervous measurement | 1.06e-03 | 87 | 151 | 4 | EFO_0009597 | |
| Disease | breast cancer (is_implicated_in) | 1.07e-03 | 150 | 151 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | 2-ketocaprylate measurement | 1.14e-03 | 10 | 151 | 2 | EFO_0800110 | |
| Disease | Holoprosencephaly sequence | 1.14e-03 | 10 | 151 | 2 | cv:C0079541 | |
| Disease | C-reactive protein measurement | NCOA6 HLA-DQA1 VPS13C CAST TMEM225B BPTF SETD5 DNAJC5 TAF4B KRTAP11-1 CAMTA1 BSN GCN1 FAM177A1 ARMH4 | 1.37e-03 | 1206 | 151 | 15 | EFO_0004458 |
| Disease | Ductal Carcinoma | 1.39e-03 | 11 | 151 | 2 | C1176475 | |
| Disease | Basal cell carcinoma | 1.39e-03 | 11 | 151 | 2 | C0007117 | |
| Disease | fibroblast growth factor 23 measurement | 1.40e-03 | 43 | 151 | 3 | EFO_0009381 | |
| Disease | glioblastoma (is_marker_for) | 1.49e-03 | 44 | 151 | 3 | DOID:3068 (is_marker_for) | |
| Disease | Thyroid carcinoma | 1.49e-03 | 44 | 151 | 3 | C0549473 | |
| Disease | Malignant neoplasm of salivary gland | 1.59e-03 | 45 | 151 | 3 | C0220636 | |
| Disease | Major Depressive Disorder | 1.62e-03 | 243 | 151 | 6 | C1269683 | |
| Disease | specific language impairment, dyslexia | 1.66e-03 | 12 | 151 | 2 | EFO_0005424, EFO_1001510 | |
| Disease | N-acetyl-2-aminooctanoate measurement | 1.66e-03 | 12 | 151 | 2 | EFO_0800567 | |
| Disease | thyroid gland carcinoma (is_marker_for) | 1.66e-03 | 12 | 151 | 2 | DOID:3963 (is_marker_for) | |
| Disease | anti-Epstein Barr virus antibody measurement | 1.66e-03 | 12 | 151 | 2 | EFO_0009273 | |
| Disease | Alzheimer disease, educational attainment | 1.76e-03 | 247 | 151 | 6 | EFO_0011015, MONDO_0004975 | |
| Disease | Gastrointestinal Stromal Sarcoma | 1.81e-03 | 47 | 151 | 3 | C3179349 | |
| Disease | Salivary Gland Neoplasms | 1.81e-03 | 47 | 151 | 3 | C0036095 | |
| Disease | atopic eczema | 1.94e-03 | 252 | 151 | 6 | EFO_0000274 | |
| Disease | hyperglycemia (is_marker_for) | 1.96e-03 | 13 | 151 | 2 | DOID:4195 (is_marker_for) | |
| Disease | skin melanoma (is_marker_for) | 1.96e-03 | 13 | 151 | 2 | DOID:8923 (is_marker_for) | |
| Disease | risk-taking behaviour | HLA-DQA1 WASHC3 BCAS1 PTCH1 BIRC6 BPTF ZNF800 CD34 ADGRL3 EPHA5 ARMH4 | 1.98e-03 | 764 | 151 | 11 | EFO_0008579 |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 2.04e-03 | 49 | 151 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | Alzheimer's disease (is_marker_for) | 2.14e-03 | 257 | 151 | 6 | DOID:10652 (is_marker_for) | |
| Disease | Gastrointestinal Stromal Tumors | 2.16e-03 | 50 | 151 | 3 | C0238198 | |
| Disease | Unipolar Depression | 2.23e-03 | 259 | 151 | 6 | C0041696 | |
| Disease | C-C motif chemokine 19 measurement | 2.27e-03 | 14 | 151 | 2 | EFO_0008047 | |
| Disease | pulmonary function measurement, FEV/FEC ratio | 2.55e-03 | 53 | 151 | 3 | EFO_0003892, EFO_0004713 | |
| Disease | Alobar Holoprosencephaly | 2.61e-03 | 15 | 151 | 2 | C0431363 | |
| Disease | Necrosis | 2.84e-03 | 55 | 151 | 3 | C0027540 | |
| Disease | Schizoaffective disorder-bipolar type | 2.98e-03 | 16 | 151 | 2 | EFO_0009965 | |
| Disease | Lobar Holoprosencephaly | 2.98e-03 | 16 | 151 | 2 | C0431362 | |
| Disease | Semilobar Holoprosencephaly | 2.98e-03 | 16 | 151 | 2 | C0751617 | |
| Disease | ovarian cancer (is_implicated_in) | 2.99e-03 | 56 | 151 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | Polydactyly | 3.12e-03 | 117 | 151 | 4 | C0152427 | |
| Disease | Holoprosencephaly | 3.36e-03 | 17 | 151 | 2 | C0079541 | |
| Disease | Malignant neoplasm of skin | 3.46e-03 | 59 | 151 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 3.46e-03 | 59 | 151 | 3 | C0037286 | |
| Disease | longevity | 3.51e-03 | 284 | 151 | 6 | EFO_0004300 | |
| Disease | response to vaccine | 3.63e-03 | 122 | 151 | 4 | EFO_0004645 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 3.63e-03 | 60 | 151 | 3 | C4722327 | |
| Disease | Sjogren's syndrome (is_implicated_in) | 3.77e-03 | 18 | 151 | 2 | DOID:12894 (is_implicated_in) | |
| Disease | Hereditary Diffuse Gastric Cancer | 4.08e-03 | 293 | 151 | 6 | C1708349 | |
| Disease | optic disc size measurement | 4.16e-03 | 205 | 151 | 5 | EFO_0004832 | |
| Disease | carotid artery disease (is_marker_for) | 4.20e-03 | 19 | 151 | 2 | DOID:3407 (is_marker_for) | |
| Disease | kidney failure (biomarker_via_orthology) | 4.20e-03 | 19 | 151 | 2 | DOID:1074 (biomarker_via_orthology) | |
| Disease | colorectal cancer, inflammatory bowel disease | 4.20e-03 | 19 | 151 | 2 | EFO_0003767, MONDO_0005575 | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 4.36e-03 | 64 | 151 | 3 | DOID:224 (implicated_via_orthology) | |
| Disease | susceptibility to hepatitis B infection measurement | 4.36e-03 | 64 | 151 | 3 | EFO_0008405 | |
| Disease | Stomach Neoplasms | 4.36e-03 | 297 | 151 | 6 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 4.58e-03 | 300 | 151 | 6 | C0024623 | |
| Disease | response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement | 4.65e-03 | 20 | 151 | 2 | EFO_0803359, EFO_0803362 | |
| Disease | polymyositis | 4.65e-03 | 20 | 151 | 2 | EFO_0003063 | |
| Disease | Neoplasms, Experimental | 4.75e-03 | 66 | 151 | 3 | C0027659 | |
| Disease | Disorder of eye | 4.79e-03 | 212 | 151 | 5 | C0015397 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TEGSRQQSSVTVSEP | 1036 | Q4LE39 | |
| TEVSSTNQVEVPDTT | 341 | Q9Y6Y1 | |
| VENDVTQTVSSFSLP | 81 | Q9P2B7 | |
| QQVSAPVVTSTTQEK | 4096 | Q9NR09 | |
| LSTAVQPNESTETTE | 1461 | P13611 | |
| TIFSPSRDVVVSQSQ | 191 | Q9BXI3 | |
| PEVTSVASFISESTQ | 1446 | Q8IZF6 | |
| ATTSQPVLTSQQIET | 531 | P11274 | |
| VQTTDGTPTSVQEVA | 446 | P35670 | |
| STNFQPIVEEITETT | 166 | Q86TY3 | |
| SSDQSQIPVIAVSVT | 566 | P54756 | |
| VAATESVTTSTQTEP | 1366 | Q9HAR2 | |
| TVSSGTQTTVQDDPE | 621 | Q9Y6D5 | |
| VTPEQTTQHTVSLNE | 3586 | Q8TCU4 | |
| EQPSCQQIVSTTHTS | 296 | Q5T5M9 | |
| TSVISTPSTEEIQSE | 516 | Q13112 | |
| LTSSDSSVIIQQAVP | 176 | P15336 | |
| SEETIIQTPSVVTQG | 646 | Q5JWR5 | |
| SSTRSIDTQTPSVQE | 341 | Q86VQ1 | |
| TQNHSALVTETTVVP | 301 | Q14161 | |
| STSPQSTEEVVQSFL | 561 | Q92624 | |
| TTQPSLTQTTVMETV | 671 | P11532 | |
| TSPFTSNETNIIEVV | 881 | Q6Q4G3 | |
| NTVTSGTATTVIEIQ | 436 | Q9HBB8 | |
| TQPEVQTQTTVSSHV | 2421 | Q12830 | |
| QTQTTVSSHVPSEAQ | 2426 | Q12830 | |
| VTVETVNSVTLTQDT | 11 | Q9Y222 | |
| RSNSTAATNEVPEVT | 101 | P01909 | |
| SFTTRNQVEPVSQTT | 561 | O95905 | |
| SSVQVVAAVAAPSST | 316 | Q5T6C5 | |
| TPTVRIESSSSQVAE | 2436 | P98160 | |
| PEVTVTSLTSSVQES | 376 | Q9Y5G9 | |
| EITTNRLTATQSTAP | 2831 | Q8WXI7 | |
| IETTHPSINTVVTNV | 4821 | Q8WXI7 | |
| QLTVSPETSTETITR | 8171 | Q8WXI7 | |
| IISNVTVTSVTLPNA | 101 | Q9ULC0 | |
| TVTSVTLPNAVSTLQ | 106 | Q9ULC0 | |
| VTITSEPTNETESSQ | 306 | O60309 | |
| VPSETTSDNLQITTQ | 2666 | Q8NEZ4 | |
| VDDSLSVSVVQTPTT | 1586 | P46821 | |
| SVSVVQTPTTFQETE | 1591 | P46821 | |
| VTSFVVEEPTNISTG | 6 | P04201 | |
| VTITSEPTNETESSQ | 306 | A6NM11 | |
| VTITSEPTNETESSQ | 306 | A6NMS7 | |
| APDVTSTQVNTVVSG | 611 | Q6P4R8 | |
| DSIVQTDQPETVISS | 171 | Q8N128 | |
| TDQPETVISSSFVNV | 176 | Q8N128 | |
| DVSTSTTINNISTPV | 2131 | Q2M2H8 | |
| AVTTTTPQVFLENTT | 1596 | Q8IWI9 | |
| STTEPVISISSNNAV | 581 | Q9NVR5 | |
| DTVIETTVANSPGTV | 66 | Q5VTL7 | |
| ESASPQSTVTVFQQT | 591 | Q16665 | |
| QIQEPTANATTTTAT | 606 | Q16665 | |
| SSSQSEITGVVQQEV | 691 | Q9UPA5 | |
| SVTVTTNQAAPSSIA | 431 | P54764 | |
| IQQPATASATSITTV | 1361 | Q9UKJ3 | |
| AAPTSVTQFLTTEVS | 2661 | Q9Y6V0 | |
| TTTASAVVAIEIPQS | 3356 | Q9Y6V0 | |
| VEVAPEASTSSASQV | 851 | Q14766 | |
| PEVSTISEVSNTGIT | 6216 | Q7Z5P9 | |
| VAVSSSAIVTSNPEV | 436 | Q9ULH7 | |
| TNVFTSAVDQTITPE | 251 | A1E959 | |
| FVTETQATQPSSAET | 376 | Q96LW2 | |
| NTSIPTNAVSVVSSV | 1741 | P50851 | |
| QIVSDPFLVVSNTST | 766 | P32004 | |
| DTLSTSLQSSPEVQV | 801 | Q8IWU2 | |
| QSSESAVSSTVNPVA | 356 | P10070 | |
| AASQSTQVPTITEGV | 476 | Q92616 | |
| ETQESTVPQSSRAQT | 146 | Q29980 | |
| QPTVTSVCSETSQEL | 206 | Q96HC4 | |
| QHEESVVPTQSTLTA | 486 | Q9NQV6 | |
| IVIQPASATETTQLT | 171 | Q9H3Z4 | |
| VTTTSAAVVSQSPQL | 401 | P52756 | |
| TTVAAVQSDIPVVSS | 186 | Q8NDX5 | |
| VPTTTTATEEQVSEP | 166 | O94880 | |
| GSNSQTVVTQEPSLT | 16 | P04211 | |
| GVDSQTVVTQEPSFS | 21 | A0A075B6I0 | |
| QITVFVTSNPITTSA | 1596 | Q14686 | |
| TVTETTVTVTTEPEN | 11 | O60927 | |
| EQIASNTTTTPQTFI | 446 | Q96EW2 | |
| TPVRSISTVNLSENS | 416 | Q9UHR4 | |
| ISTVNLSENSSVVIP | 421 | Q9UHR4 | |
| LVDQTSENAPTTVSR | 406 | O75460 | |
| VQNTATLEITSPTTE | 911 | Q4L180 | |
| TISTASVRPAQEEQS | 751 | Q96RY5 | |
| QQTPTSTSCTITDVQ | 81 | Q14213 | |
| PSSEVTVTDITANSI | 216 | O95931 | |
| TEAVSTASTVAIPNI | 471 | O75976 | |
| EVVSQTPASTTQAGA | 541 | P20810 | |
| VPVAQVTTTSTTDAD | 21 | Q8IUC1 | |
| EFSVTSNETITVSPE | 131 | P48723 | |
| EPTANSTVTETNSTQ | 241 | Q9NRM1 | |
| EQTTASPDIRNTTVT | 506 | Q96PD2 | |
| SFVLPVESTQDVSSQ | 551 | Q9Y4K1 | |
| VESTQDVSSQVIPES | 556 | Q9Y4K1 | |
| TDNVATSSPETTEIS | 56 | O75363 | |
| SSSSSQIPVVGVVTE | 21 | A5D8W1 | |
| EEETNIISSIVPSTQ | 2001 | Q9C0D2 | |
| QQKEITQSPSTSTIT | 871 | Q9ULU4 | |
| VTSLTEVASNPATIT | 481 | Q9BZW2 | |
| NTTTANTATVEVLAP | 1341 | Q58EX2 | |
| QSTVGTEVTSQVDNL | 486 | Q5VV67 | |
| TATVSVTVIDVNENP | 481 | P19022 | |
| QSQTSVISTVFTTPA | 111 | P28906 | |
| VTNVVPFEVSLTTST | 456 | P12830 | |
| SLSQIPETNSEETTV | 326 | Q9H756 | |
| TSSTEVQVEQATPIS | 586 | Q9HC10 | |
| NDNAPEVTITSVTTA | 341 | Q9Y5H4 | |
| EVTITSVTTAVPENF | 346 | Q9Y5H4 | |
| TQSQTTVLVVTSGTV | 86 | Q9NPJ8 | |
| VEISTPVTISAQASS | 241 | Q685J3 | |
| VDSNSPVITSTEVSS | 1656 | Q685J3 | |
| TTPVDSKTQVTNSTE | 2066 | Q685J3 | |
| VANSEVSTLSTTPVD | 2291 | Q685J3 | |
| VDSNSPVVTSTEVSS | 3071 | Q685J3 | |
| VVSSEVNTLSTTPVD | 3411 | Q685J3 | |
| VNTLSTTPVDSNTLV | 3416 | Q685J3 | |
| TLTITVFTNPTQVAT | 151 | Q13761 | |
| PQQTVTRAETTSNIT | 131 | Q92750 | |
| SSVQSVAVPTSVVTV | 196 | Q92750 | |
| PATSVNSTEETATTV | 536 | Q86TM6 | |
| STPTVSTSEVTSQQE | 16 | Q5H9L4 | |
| STSEVTSQQEPQILV | 21 | Q5H9L4 | |
| AQTTRLTATEAQTTP | 151 | Q14242 | |
| TQITTVEDTPSDIPT | 3101 | O75445 | |
| NFATIPQDTVTEITS | 201 | Q9BUD6 | |
| TTVVTNGSTELVVQE | 726 | O60522 | |
| PSSVQKETQVTAETV | 206 | P0DP42 | |
| EAVITPVASATQSVS | 381 | P28749 | |
| SQVSDSVSGQTVVDP | 256 | O94906 | |
| TTDTVTEVVVPFNQI | 321 | P25105 | |
| VDKTTTVSVSQQPVS | 36 | Q7Z3K3 | |
| VSLQETSSIVSVPSE | 581 | P28715 | |
| TSSIVSVPSEAVDNV | 586 | P28715 | |
| TVTQDTLSCQSPEST | 691 | Q13635 | |
| QPITTVTASASVTVA | 1366 | Q13635 | |
| EAPESEVSNSVSNVT | 561 | Q9C0A6 | |
| VTQFSSVPVSVVSDS | 266 | P43490 | |
| EPQINITTADTTITT | 141 | Q99935 | |
| SSLTSAQAVAVTPEQ | 1706 | Q7RTU9 | |
| TSSFETVQINVIPTS | 141 | Q99941 | |
| NRFVLSTSQVPTTTE | 651 | P28329 | |
| ATDSLQTVQPSISQT | 16 | Q5K130 | |
| ESINTVQTEHTVQPS | 271 | O43298 | |
| EQTTVEQQSVFTAPT | 156 | Q96Q45 | |
| QTSVDVTAFSQSPEL | 286 | A4UGR9 | |
| VVSTQVATVTQSGLS | 481 | P52747 | |
| PAVSSVVNSIQVLTS | 151 | Q9P2E9 | |
| VVIEASSTPQVTANE | 301 | Q6ZNA4 | |
| SSTPQVTANEEINVT | 306 | Q6ZNA4 | |
| GTEVIQVTNVSPSAS | 31 | Q05519 | |
| SDVVVSTPTPSSIQV | 616 | O94991 | |
| SQALPTTEVTNTQAS | 116 | Q12816 | |
| SVAQTVSTPTTQDQT | 291 | O14776 | |
| ATSISNIISIETPNT | 121 | Q6NW29 | |
| LQVAAPVTVFTESTT | 2216 | P12270 | |
| EEEEQQPATTTATST | 1036 | Q9H7N4 | |
| EEVSQPVSASQSSLS | 301 | Q8NCP5 | |
| ATAVVVVELSSPSTN | 346 | P48594 | |
| VIPQSSISTNAVVVD | 1251 | Q709C8 | |
| TVEPTILNATNTSLT | 1451 | P08922 | |
| VISDSALEQQTTPSS | 641 | Q2KHR2 | |
| SSEPTAQDTTAVQLS | 116 | A0A0U1RQS6 | |
| SLQTSDSTVPASVVI | 1421 | Q9UL36 | |
| PQEITLTISELNTTS | 1521 | Q9UL36 | |
| VTESSSTPEQTEVQI | 156 | Q2TB10 | |
| STPEQTEVQIQETST | 161 | Q2TB10 | |
| QETSTEQSKTVPVTD | 171 | Q2TB10 | |
| EVTSSISINSSEVPE | 566 | Q9UQR1 | |
| APTTSSQQAVLESTQ | 1026 | Q9H4A3 | |
| ISTSVIQSEVTVPTE | 1366 | Q9H4A3 | |
| VSASVQSVPTQTATL | 1076 | Q9Y3S1 | |
| SFPISVSNVVSEVEN | 156 | Q9BXT5 | |
| ETTDSPVNVTITVTA | 751 | P0DP72 | |
| DVTVEVSPLNVTSVT | 81 | Q9Y3C0 | |
| VQSSTPEQSPEETTQ | 166 | O95125 | |
| TVQFVSEETVPATQT | 66 | Q9NTW7 | |
| SEETVPATQTQTTTR | 71 | Q9NTW7 | |
| PATQTQTTTRTITSE | 76 | Q9NTW7 | |
| TITSETQTITVSAPE | 86 | Q9NTW7 | |
| EITVCPETQLSSSET | 441 | Q96RL1 | |
| VVSTSVISEQSEQSV | 216 | P18583 | |
| PSVSVQESTVTVSEP | 1436 | P18583 | |
| QESTVTVSEPAVTVS | 1441 | P18583 | |
| TVSEPAVTVSEQTQV | 1446 | P18583 | |
| AVTVSEQTQVIPTEV | 1451 | P18583 | |
| EQTQVIPTEVAIEST | 1456 | P18583 | |
| QIAPSISVSVSETSE | 946 | Q9BVV6 | |
| PVQTVTSAEESSADV | 831 | Q9NR99 | |
| TTTSFPNETATIISQ | 216 | Q9NQS3 |